CD19 and lymphoma: For this purpose, Rag2– γc– mice (n = 22) were intravenously injected with CD19/CD80/CD86-positive Raji lymphoma cells and treated with CAR (2nd Gen) T cells, corresponding to the Kymriah product (Novartis).